Author:
Scheper W,van Dorp S,Kersting S,Pietersma F,Lindemans C,Hol S,Heijhuurs S,Sebestyen Z,Gründer C,Marcu-Malina V,Marchant A,Donner C,Plachter B,Vermijlen D,van Baarle D,Kuball J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference52 articles.
1. Boeckh M, Geballe AP . Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 2011; 121: 1673–1680.
2. Einsele H, Ehninger G, Hebart H, Weber P, Dette S, Link H et al. Incidence of local CMV infection and acute intestinal GVHD in marrow transplant recipients with severe diarrhoea. Bone Marrow Transplant 1994; 14: 955–963.
3. Takemoto Y, Takatsuka H, Wada H, Mori A, Saheki K, Okada M et al. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship. Bone Marrow Transplant 2000; 26: 77–81.
4. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M . High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185: 273–282.
5. Behrendt CE, Rosenthal J, Bolotin E, Nakamura R, Zaia J, Forman SJ . Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy. Biol Blood Marrow Transplant 2009; 15: 54–60.